Company Filing History:
Years Active: 2022-2024
Title: Innovations by Taylor Harding: A Leader in T Cell and B Cell Receptor Profiling
Introduction
Taylor Harding, an innovative inventor based in Chicago, IL, holds two patents that highlight his contributions to the fields of immunology and next-generation sequencing. His work is pivotal in understanding T cell receptor (TCR) and B cell receptor (BCR) profiles, which are essential for diagnosing and treating various medical conditions.
Latest Patents
Harding's latest patents focus on TCR/BCR profiling using enrichment with pools of capture probes. These inventions involve systems and methods designed to profile the TCR and BCR repertoire through advanced next-generation sequencing techniques. The patents also provide crucial insights for diagnosing, treating, or predicting infections and diseases based on TCR/BCR profile data from subjects requiring medical attention.
Career Highlights
Throughout his career, Taylor has contributed significantly to organizations such as Tempus Labs, Inc. and Tempus AI, Inc. His innovative approaches and dedication to research have positioned him as a key player in the development of advanced diagnostic tools in the healthcare industry.
Collaborations
In his professional journey, Taylor has collaborated with talented individuals like Jason Perera and Brittany Mineo. Their combined efforts have led to advancements in technologies that enhance our understanding of TCR and BCR repertoires, further driving the progress of medical diagnostics.
Conclusion
Taylor Harding's contributions to the realm of immunology and next-generation sequencing reflect a deep commitment to innovation. With two patents to his name, he continues to lead the charge in developing systems that are vital for the diagnosis and treatment of various medical conditions, showcasing the significant impact one inventor can have in the world of science and technology.